CRIS Current Research Information System

LEWIS, RUSSEL EDWARD
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.062
EU - Europa 4.127
AS - Asia 2.465
AF - Africa 287
SA - Sud America 47
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 5
Totale 14.006
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.042
GB - Regno Unito 1.385
CN - Cina 921
SG - Singapore 633
DE - Germania 601
SE - Svezia 560
IT - Italia 506
VN - Vietnam 488
IN - India 286
IE - Irlanda 218
RU - Federazione Russa 212
FR - Francia 182
ZA - Sudafrica 124
EE - Estonia 112
UA - Ucraina 81
BG - Bulgaria 59
EG - Egitto 57
FI - Finlandia 49
TG - Togo 46
CI - Costa d'Avorio 32
CH - Svizzera 31
JO - Giordania 31
BE - Belgio 28
ES - Italia 24
NG - Nigeria 19
BR - Brasile 18
NL - Olanda 18
ID - Indonesia 16
RO - Romania 15
AT - Austria 14
CA - Canada 14
AU - Australia 12
AR - Argentina 11
CL - Cile 11
HK - Hong Kong 10
JP - Giappone 10
LB - Libano 10
KR - Corea 9
IR - Iran 8
GR - Grecia 7
TR - Turchia 7
HU - Ungheria 6
PK - Pakistan 6
PL - Polonia 5
BD - Bangladesh 4
CZ - Repubblica Ceca 4
PH - Filippine 4
TN - Tunisia 4
UZ - Uzbekistan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
HN - Honduras 3
IL - Israele 3
MY - Malesia 3
PT - Portogallo 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
EC - Ecuador 2
EU - Europa 2
LT - Lituania 2
LY - Libia 2
PE - Perù 2
SC - Seychelles 2
AE - Emirati Arabi Uniti 1
BZ - Belize 1
CO - Colombia 1
CY - Cipro 1
FK - Isole Falkland (Malvinas) 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MN - Mongolia 1
MX - Messico 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
SN - Senegal 1
VE - Venezuela 1
Totale 14.006
Salva come PNG Salva come JPEG
Città #
Southend 1.275
Fairfield 1.142
Singapore 563
Ashburn 535
Chandler 491
Woodbridge 484
Wilmington 483
Houston 414
Seattle 414
Cambridge 378
Dong Ket 338
Princeton 321
Ann Arbor 265
Dublin 217
Boardman 200
Santa Clara 192
Westminster 134
Bologna 124
Nanjing 116
Berlin 105
Padova 96
Jinan 83
Shenyang 73
Dearborn 68
Saint Petersburg 67
Beijing 62
Sofia 59
New York 58
Cairo 57
San Diego 55
Hebei 48
Helsinki 48
Lomé 46
Nanchang 46
Changsha 40
Falls Church 35
Bremen 33
Abidjan 32
Redmond 32
Amman 31
Olalla 28
Jiaxing 27
Medford 27
Shanghai 27
Brussels 26
Florence 25
Des Moines 24
Tianjin 24
Zhengzhou 23
Guangzhou 22
Turin 21
Los Angeles 20
Abeokuta 19
Ningbo 19
Redwood City 18
Bühl 17
Bern 16
San Francisco 16
Chicago 15
Haikou 14
Jakarta 14
Milan 14
Taizhou 14
Lanzhou 13
Hangzhou 12
Kunming 12
Fuzhou 11
Buenos Aires 10
Casalecchio di Reno 10
Leganés 10
London 10
Vienna 10
Taiyuan 9
Washington 9
Chengdu 8
Lausanne 8
Moscow 8
Norwalk 8
Phoenix 8
Pune 8
Toronto 8
Costa Mesa 7
Rome 7
São Paulo 7
Hefei 6
Leawood 6
Mountain View 6
Muizenberg 6
Santiago 6
Shijiazhuang 6
Wuhan 6
Chongqing 5
Foshan 5
Frankfurt Am Main 5
Frankfurt am Main 5
Hong Kong 5
Incheon 5
Reggio Emilia 5
Shenzhen 5
Sydney 5
Totale 10.010
Salva come PNG Salva come JPEG
Nome #
Acute Invasive Fungal Rhinosinusitis in Immunocompromised Patients: Role of an Early Diagnosis 185
Antifungal prophylaxis in liver transplant recipients: one size does not fit all 181
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study 181
Carbapenem-resistant Klebsiella pneumoniae colonization at liver transplantation:a management challenge 171
Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study 164
Characterization of antibody response in neuroinvasive infection caused by Toscana virus 149
Ceftolozane-Tazobactam Treatment of Hypervirulent Multidrug Resistant Pseudomonas aeruginosa Infections in Neutropenic Patients 147
Carbapenem resistant bacteria in Intensive Care Unit during COVID-19 pandemic: Multicenter before-after cross sectional study 143
Computerized tomographic pulmonary angiography discriminates invasive mould disease of the lung from lymphoma 136
In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment 136
Computed tomographic pulmonary angiography for diagnosis of invasive mold diseases in patients with hematological malignancies 135
Beyond biomarkers: How enhanced CT imaging can improve the diagnostic-driven management of invasive mould disease 135
Larger size of donor alloreactive NK cell repertoire correlates with better response to NK cell immunotherapy in elderly acute myeloid leukemia patients 133
Implementation of a Meningitis Care Bundle in the Emergency Room Reduces Mortality Associated With Acute Bacterial Meningitis 132
Differences in the rate of carbapenem-resistant Enterobacteriaceae colonisation or Clostridium difficile infection following frontline treatment with tigecycline vs. meropenem for intra-abdominal infections 132
Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy 131
Animal Models for Studying Triazole Resistance in Aspergillus fumigatus 126
Donor Natural Killer (NK) Alloreactivity Predicts Long-Term Relapse-Free Survival in Acute Myeloid Leukemia Patients Undergoing Immunotherapy with NK Cells 126
Activity of Deferasirox in Mucorales: Influences of Species and Exogenous Iron 125
High-dose Weekly Liposomal Amphotericin B Antifungal Prophylaxis in Patients Undergoing Liver Transplantation 123
Liver transplantation is associated with good clinical outcome in patients with active tuberculosis and acute liver failure due to anti-tubercular treatment 121
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 119
Risk factors for recurrent carbapenem resistant Klebsiella pneumoniae bloodstream infection: a prospective cohort study 117
Aggressive versus conservative initiation of antibiotics 117
Successful treatment of bilateral endogenous Fusarium solani endophthalmitis in a patient with acute lymphocytic leukaemia 116
A risk prediction score for invasive mold disease in patients with hematological malignancies 115
Epidemiology and outcomes of bloodstream infection in patients with cirrhosis. 114
Invasive Mucormycosis. In Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 8th Edition 114
Prognostic Role of Bacterial and Fungal Infections in Patients with Liver Cirrhosis with and without Acute-on-Chronic Liver Failure: A Prospective 2-Center Study 114
Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation with Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999-2015 109
Comparative serum bactericidal activity of meropenem-based combination regimens against extended-spectrum beta-lactamase and KPC-producing Klebsiella pneumoniae 107
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters 106
Anidulafungin versus Caspofungin in a Mouse Model of Candidiasis Caused by Anidulafungin-Susceptible Candida parapsilosis Isolates with Different Degrees of Caspofungin Susceptibility 105
Development and internal validation of a model for predicting 60-day risk of invasive mould disease in patients with haematological malignancies 105
Treatment of MDR-Gram negative infections in the 21st century: a never ending threat for clinicians 104
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma 102
The potential impact of antifungal drug resistance mechanisms on the host immune response to Candida. 101
Prognostic utility of the new definition of difficult-to-treat resistance among patients with gram-negative bloodstream infections 101
Retrospective cohort analysis of liposomal amphotericin b nephrotoxicity in patients with hematological malignancies 100
Enemy of the (immunosuppressed) state: an update on the pathogenesis of Aspergillus fumigatus infection 99
Potential role of T2Candida in the management of empirical antifungal treatment in patients at high risk of candidaemia: a pilot single-centre study 99
Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study 99
Early low-dose computed tomography with pulmonary angiography to improve the early diagnosis of invasive mould disease in patients with haematological malignancies: A pilot study 99
null 98
Breakthrough invasive mold infections in the hematology patient: Current concepts and future directions 98
Comparative Pharmacodynamics of Posaconazole in Neutropenic Murine Models of Invasive Pulmonary Aspergillosis and Mucormycosis 97
Comparative in vivo dose-dependent activity of caspofungin and anidulafungin against echinocandin-susceptible and -resistant Aspergillus fumigatus 97
Toll-deficient Drosophila are resistant to infection by Pneumocystis spp. Additional evidence of specificity to mammalian hosts 96
null 96
Influence of host immunosuppression on CT findings in invasive pulmonary aspergillosis 94
Innate inflammatory response and immunopharmacologic activity of micafungin, caspofungin, and voriconazole against wild-type and FKS mutant Candida glabrata isolates 94
Proangiogenic Growth Factors Potentiate In Situ Angiogenesis and Enhance Antifungal Drug Activity in Murine Invasive Aspergillosis 94
Efficacy of Caspofungin in Neutropenic and Corticosteroid-Immunosuppressed Murine Models of Invasive Pulmonary Mucormycosis 93
Predictors of mortality in multidrug-resistantKlebsiella pneumoniaebloodstream infections 93
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study 93
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline 92
null 92
Saprochaete clavata infections in patients undergoing treatment for haematological malignancies: A report of a monocentric outbreak and review of the literature 92
Serum Galactomannan Diagnosis of Breakthrough Invasive Fungal Disease 91
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: A prospective observational multicentre study 91
In vitro interaction of ceftazidime–avibactam in combination with different antimicrobials against KPC-producing Klebsiella pneumoniae clinical isolates 91
A prospective international Aspergillus terreus survey: an EFISG, ISHAM and ECMM joint study 91
null 91
null 90
Antifungal agents 89
Combination Therapy for Mucormycosis: Why, What, and How? 88
Development and applications of prognostic risk models in the management of invasive mold disease 88
Echinocandin Resistance in Candida Species: Mechanisms of Reduced Susceptibility and Therapeutic Approaches 87
Impaired bactericidal but not fungicidal activity of polymorphonuclear neutrophils in patients with chronic lymphocytic leukemia 87
The role of extended infusion β-lactams in the treatment of bloodstream infections in patients with liver cirrhosis 87
In vitro interactions among echinocandins against Aspergillus fumigatus: lack of concordance among methods 86
Mucormycosis Caused by Unusual Mucormycetes, Non-Rhizopus, -Mucor, and -Lichtheimia Species 86
Fungal Drug Resistance and Pharmacologic Considerations of Dosing Newer Antifungal Therapies 86
Mucorales-specific T cells in patients with hematologic malignancies 86
How Does Antifungal Pharmacology Differ for Mucormycosis Versus Aspergillosis? 86
Future Directions in Mucormycosis Research 85
Effect of preexposure to triazoles on susceptibility and virulence of Rhizopus oryzae 85
Using carbapenems for carbapenem-resistant Klebsiella pneumoniae-Are we flogging a dead (work)horse antibiotic? 85
Live monitoring and analysis of fungal growth, viability, and mycelial morphology using the incucyte neurotrack processing module 85
Clinical Pharmacokinetics, Pharmacodynamics, Safety and Efficacy of Liposomal Amphotericin B 84
Treatment of carbapenem-resistantKlebsiella pneumoniae: the state of the art 83
Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study 83
Fitness and Virulence Costs of Candida albicans FKS1 Hot Spot Mutations Associated With Echinocandin Resistance 83
Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B 83
Risk factors for treatment failure in patients receiving β-lactam/β-lactamase inhibitor combinations for Enterobacteriaceae bloodstream infection: A retrospective, single-centre, cohort study 83
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study 83
Importance of Pharmacokinetic Considerations for Selecting Therapy in the Treatment of Invasive Fungal Infections 82
Current Concepts in Antifungal Pharmacology 82
Treatment principles for the management of mold infections 82
The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study 82
Azole-resistance in Aspergillus terreus and related species: An emerging problem or a rare Phenomenon? 82
Effectiveness of Primary Anti-Aspergillus Prophylaxis during Remission Induction Chemotherapy of Acute Myeloid Leukemia 81
Initial use of combination treatment does not impact survival of 106 patients with haematologic malignancies and mucormycosis: a propensity score analysis 81
Epidemiology and treatment of mucormycosis 80
Defining the role of echinocandin catechol functional groups in the development of secondary hepatocellular carcinoma 80
Preexposure to Isavuconazole Increases the Virulence of Mucorales but Not Aspergillus fumigatus in a Drosophila melanogaster Infection Model 80
Tacrolimus Enhances the Potency of Posaconazole Against Rhizopus oryzae In Vitro and in an Experimental Model of Mucormycosis 79
Macrophage Reporter Cell Assay for Screening Immunopharmacological Activity of Cell Wall-Active Antifungals 79
Weekly liposomal amphotericin B as secondary prophylaxis for invasive fungal infections in patients with hematological malignancies 79
How I treat mucormycosis 78
Totale 10.343
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.684
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.684
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.739 0 0 0 0 0 425 513 646 608 243 127 177
2020/20211.923 386 166 80 48 58 48 54 79 160 106 82 656
2021/20222.674 188 61 166 178 275 154 90 215 134 215 479 519
2022/20232.455 254 312 132 367 185 188 80 171 443 75 159 89
2023/2024771 68 130 47 65 69 141 108 18 17 42 45 21
2024/20251.658 108 579 215 242 386 128 0 0 0 0 0 0
Totale 14.414